Martingale Asset Management L P Meridian Bioscience Inc Transaction History

Martingale Asset Management L P

$4.27 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $476,601 - $517,475	-15,424 Reduced 27.15%	41,387 $1.31 Million
Q2 2022 Aug 11, 2022	SELL	$23.75 - $31.69 $503,048 - $671,225	-21,181 Reduced 27.16%	56,811 $1.73 Million
Q1 2022 May 12, 2022	BUY	$19.97 - $26.94 $152,351 - $205,525	7,629 Added 10.84%	77,992 $2.02 Million
Q4 2021 Feb 11, 2022	BUY	$17.46 - $21.61 $429,550 - $531,649	24,602 Added 53.76%	70,363 $1.44 Million
Q3 2021 Nov 12, 2021	BUY	$17.35 - $22.5 $98,981 - $128,362	5,705 Added 14.24%	45,761 $880,000
Q2 2021 Aug 13, 2021	SELL	$18.01 - $28.32 $228,708 - $359,635	-12,699 Reduced 24.07%	40,056 $888,000
Q1 2021 May 13, 2021	SELL	$19.76 - $29.89 $211,728 - $320,271	-10,715 Reduced 16.88%	52,755 $1.38 Million
Q4 2020 Feb 10, 2021	SELL	$15.73 - $21.66 $204,411 - $281,471	-12,995 Reduced 16.99%	63,470 $1.19 Million
Q3 2020 Nov 12, 2020	BUY	$13.54 - $26.41 $12,145 - $23,689	897 Added 1.19%	76,465 $1.3 Million
Q2 2020 Aug 10, 2020	SELL	$7.84 - $23.29 $580,599 - $1.72 Million	-74,056 Reduced 49.49%	75,568 $1.76 Million
Q1 2020 May 11, 2020	SELL	$5.57 - $11.5 $530,787 - $1.1 Million	-95,294 Reduced 38.91%	149,624 $1.26 Million
Q4 2019 Feb 10, 2020	SELL	$7.9 - $10.14 $930,762 - $1.19 Million	-117,818 Reduced 32.48%	244,918 $2.39 Million
Q3 2019 Nov 13, 2019	BUY	$9.17 - $12.01 $1.34 Million - $1.75 Million	145,638 Added 67.08%	362,736 $3.44 Million
Q2 2019 Aug 13, 2019	SELL	$10.88 - $17.6 $1.24 Million - $2.01 Million	-114,304 Reduced 34.49%	217,098 $0
Q1 2019 May 08, 2019	BUY	$15.51 - $17.61 $587,829 - $667,419	37,900 Added 12.91%	331,402 $0
Q4 2018 Feb 11, 2019	BUY	$14.52 - $19.72 $299,112 - $406,232	20,600 Added 7.55%	293,502 $5.1 Million
Q3 2018 Nov 09, 2018	BUY	$14.85 - $16.35 $54,974 - $60,527	3,702 Added 1.38%	272,902 $0
Q2 2018 Aug 09, 2018	BUY	$13.8 - $16.8 $16,560 - $20,160	1,200 Added 0.45%	269,200 $0
Q1 2018 May 11, 2018	BUY	$13.8 - $16.2 $1.2 Million - $1.41 Million	87,010 Added 48.07%	268,000 $0
Q4 2017 Feb 12, 2018	BUY	$13.55 - $15.8 $1.19 Million - $1.39 Million	87,815 Added 94.25%	180,990 $0
Q3 2017 Nov 13, 2017	BUY	$13.45 - $14.35 $1.25 Million - $1.34 Million	93,175	93,175 $1.33 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account